Full Text View
Tabular View
No Study Results Posted
Related Studies
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
This study has been completed.
Study NCT00158990   Information provided by Hadassah Medical Organization

First Received on September 8, 2005.   Last Updated on January 2, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depression
Bipolar Disorder
Unipolar Depression
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
triiodothyronine
sertraline
More general drug interventions related to this trial
Antidepressive Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Hadassah Medical Organization
Stanley Medical Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services